General MedicationsORALGeneric

ABACAVIR SULFATE

Standard Dose

300MG

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview ABACAVIR SULFATE is listed in Drugs@FDA under application 078742 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient ABACAVIR SULFATE Form and strength TABLET; ORAL - 300MG Sponsor MATRIX LABS Submission history Latest submission status date: 2007-04-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview ABACAVIR SULFATE is listed in Drugs@FDA under application 078742 (ANDA). Marketing status: None (Tentative Approval) Active ingredient ABACAVIR SULFATE Form and strength TABLET; ORAL - 300MG Sponsor MATRIX LABS Submission history Latest submission status date: 2007-04-05 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.